George Pothoulakis specializes in the representation of emerging growth companies and top-tier venture capital funds, with extensive experience in the life science and software industry.
George advises start-up, emerging growth and public companies, as well as a number of leading venture capital firms, in all areas of general corporate/securities law and in a variety of different transactions (ex. venture financings, M&A and public offerings). His practice spans the entire corporate lifecycle, from inception to exit/liquidity, and includes the representation of companies from various industries (ex. biotech, pharma, digital health, consumer internet and software). George regularly serves as principal outside counsel to his clients and takes great pride in providing them with thoughtfully tailored advice on complex corporate and strategic matters.
In addition to his extensive experience in private practice, George recently served as Director & Senior Counsel of the Boehringer Ingelheim Venture Fund, where he oversaw and supported all legal aspects of the venture fund's investment activities in the United States and Canada. During his time there, George also supported the venture fund's parent pharma company as lead counsel in several global financing and M&A transactions.
During law school, George was Executive Editor of the Washington University Law Review and also served as a Judicial Extern to the Honorable Kim McLane Wardlaw at the United States Court of Appeals for the Ninth Circuit.